Abstract
A laparostomy procedure, a critical intervention frequently employed in both trauma and non-trauma patients, is a key component of damage control resuscitation. The use of a vertical traction device (VTD), specifically Fasciotens® Abdomen (FTA), is a relatively novel technology that prevents fascial retraction and facilitates primary fascial closure. This report describes the case of a male in his 20s with severe pancreatitis, complicated by multi-organ failure and abdominal compartment syndrome (ACS), necessitating decompressive laparotomy. FTA was applied alongside botulinum toxin (Botox) and negative pressure wound therapy (NPWT), achieving definitive closure within 10 days. Fascial distance was reduced by 8 cm within 48 hours of FTA application. This case highlights FTA's efficacy and safety, supported by the Liverpool Hospital Trauma Acute Care Surgery (TACS) wound bundle.